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aEastern Kentucky University, Lexington, KY, USA
bLexington Forensic Neuropsychiatry, Lexington, KY, USA
Abstract.
BACKGROUND: Forensic neuropsychiatric assessment requires thorough consideration of malingering and response bias.
Neuropsychiatric evaluations are complicated due to the multiple domains in which symptoms and impairment present. Moreover,
symptom exaggeration in these evaluations can also present along various symptom domains (e.g., psychological, neurocognitive,
somatic). Consequently, steps must be taken to ensure adequate coverage of response bias across all three domains of function.
PURPOSE: The following article reviews the conceptualization of malingering in neuropsychiatric settings, as well as various
approaches and measures that can be helpful in the assessment of malingering and response bias.
CONCLUSIONS:Forensic neuropsychiatric assessment requires thorough consideration of malingering and response bias. These
evaluations are complicated due to the multiple domains in which symptoms and impairment present. Performance and symptom
validity measures should be routinely included in these evaluations. Collaboration between psychiatry and psychology can provide
the optimal multi-method approach needed for thorough neuropsychiatric assessment in forensic cases. We illustrate our points
with two case studies from forensic traumatic brain injury neuropsychiatric evaluations.
Keywords: Malingering, response bias, neuropsychiatry, forensic
1. Introduction
It is common practice to systematically review and
utilize objective test data in the examination of brain
injury, particularly in compensation-seeking cases of
mild traumatic brain injury (mTBI) and other neuropsy-
chiatric conditions. It is well-recognized that secondary
gain and financial incentives influence clinical pre-
sentations during routine treatment and particularly in
forensically-related evaluations. In a widely cited study,
the base rates of malingering and symptom exaggera-
tion were estimated by forensically-oriented diplomates
of the American Board of Clinical Neuropsychology
across various settings (Mittenberg, Patton, Canyock, &
Condit, 2002). The estimates of malingering and
∗Address for correspondence: Dr. Dustin B. Wygant, Department
of Psychology, Eastern Kentucky University, 521 Lancaster Ave.,
Richmond, KY 40475, USA. Tel.: +1 859 622 1105; Fax: +1 859 622
5871; E-mail: Dustin.wygant@eku.edu.
symptom exaggeration ranged between 18% and 33%
across personal injury, disability, criminal, and medi-
cal cases. Similar estimates among TBI litigants was
reported by Larrabee (2003). Malingered pain symp-
toms were estimated to be between 20% and 50%
among chronic pain patients where financial incentive
is present (Greve, Ord, Bianchini, & Curtis, 2009).
The issue of evaluating response bias and symptom
exaggeration has been addressed in various position
statements by professional organizations such as the
National Academy of Neuropsychology (Bush et al.,
2005), the American Academy of Clinical Neuropsy-
chology (Heilbronner et al., 2009), and more recently
by the Association for Scientific Advancement in Psy-
chological Injury and Law (Bush, Heilbronner, & Ruff,
2014). These position statements, as well as standards in
forensic psychiatry (Gutheil & Simon, 2002), all point
to the necessity of thoroughly and objectively assessing
response bias in forensically-related evaluations.
1053-8135/15/$35.00 © 2015 – IOS Press and the authors. All rights reserved
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2. Neuropsychiatric assessment of malingering
For the physician conducting a TBI examination,
the medical model of neuropsychiatric assessment and
diagnosis is based upon a triad: (1) a complete med-
ical history; (2) a face-to-face mental status and/or
neurological examination; and (3) laboratory testing to
confirm or refute elements of the differential diagno-
sis. It is the third portion of this triad which separates
physician clinicians from their psychologist clinician
counterparts. It has become the standard of practice
for the neuropsychiatric assessment of persons with
a history of TBI that the examination includes a sig-
nificant neuropsychological and psychological testing
component (Granacher, 2015). Thus, the neuropsycho-
logical and psychological assessment component of a
neuropsychiatric assessment in TBI cases includes a
collateral collaboration utilized by the physician. The
neuropsychological component of the neuropsychiatric
examination is to determine neurocognitive status using
normed brain-based psychometrics, while the psycho-
logical portion of the neuropsychiatric TBI assessment
is to determine emotional status using standardized psy-
chological testing.
TBI cases that are evaluated within the context of a
disability determination, fitness-for-duty examination,
litigation in personal injury, and other medical-legal
contexts require consideration of malingering. As noted
earlier, exclusion of this consideration in a TBI exami-
nation falls short of practice standards (e.g., Bush et al.,
2005, 2014; Heilbronner et al., 2009; Gutheil & Simon,
2002). Larrabee and Rohling (2013) have argued that
the functional areas of a comprehensive neuropsy-
chological evaluation during TBI assessment require
performance validity testing (PVT) and/or symptom
validity testing (SVT). Clinicians are required to prac-
tice using the best available evidence and, thus, the
neurocognitive assessment component of a neuropsy-
chiatric TBI evaluation is more likely to meet this
standard if PVT and SVT measures have been applied
during examination.
Recently, it has been determined that the presence of
brain lesions following TBI does not obviate or negate
the individual’s ability to provide adequate performance
on measures of symptom validity or performance valid-
ity during TBI assessment (McBride et al., 2013).
Granacher and Berry (2008) have previously reported
how malingerers may present to their physicians with
a variety of feigned complaints. There are three basic
ways to malinger a medical examination, and all three of
these could arise in many various forms during a neu-
ropsychiatric assessment of persons with a history of
TBI: (1) presentation of false cognitive or neuropsycho-
logical signs and symptoms; (2) presentation of false
psychiatric signs and symptoms; and (3) presentations
of false somatic (physical) signs and symptoms.
For physicians, it is critical to incorporate psycho-
logical symptom validity and performance validity
assessment within the overall evaluation of any
neuropsychiatric condition. It is argued that these psy-
chological and neuropsychological metrics enhance the
overall evaluation, put the clinician on a surer footing
in formulating and evaluating a differential diagno-
sis, and for those cases that may come to litigation
or other medical-legal disposition, the physician can
be confident that the best evidence possible has been
collected scientifically to ensure that the results of the
examination and the diagnoses derived therefrom are
of the highest sensitivity and specificity (Granacher,
2015). Thus, it is critically important that a quality neu-
ropsychiatric examination for TBI or any other brain
condition use embedded and free-standing SVT and
PVT measures during the overall assessment.
Assessing the complaints of a patient who has sus-
tained a mTBI can be particularly challenging. It is
argued today that research studies attempting to delin-
eate mTBI from a control group should always use a
trauma control group (such as orthopedically injured
patients) matched to the degree possible on age, educa-
tion, and gender (Larrabee, 2012). The weakest research
designs of symptom and performance validity involving
TBI are those employing clinical samples of conve-
nience, such as might be aggregated from a clinic
that specializes in treatment of persons with persist-
ing symptoms one to two years post-mTBI. One of the
most sophisticated research designs to evaluate mTBI
has been produced by Dikmen et al. (1995). These
researchers have conducted what is arguably, among
many, to be the best prospective outcome study of the
complete range of TBI severity. They compared patients
with TBI at six different levels of severity, defined by the
time to follow commands (the highest level of function
on the motor component of the Glasgow Coma Scale).
This measure is not affected by the presence of intuba-
tion, which can negatively affect the verbal component
of theGCS. In theDikmenetal. study(1995), themildest
level of injury was represented by the group that took
less than one hour to develop ability to follow com-
mands completely, whereas the most severely injured
TBI group took 29 days or more to demonstrate ability
to follow commands. Dikmen et al. (1995) collected a
large trauma control group as part of the data reported in
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this study. They compared an mTBI group with a control
sample that had been admitted to the hospital because of
traumatic injuries to the body, not involving the head.
By using such a control group, Dikmen and colleagues
were able to adjust for socioeconomic status as well as
for psychosocial factors associated with TBI, and the
experience of sufficient injury to be transported to the
hospital, as well as the potentially confounding effects
of pain (Larrabee, 2012). There were no differences
between the mTBI group and the trauma control group
with regard to age, education, or gender. Both the TBI
group and the trauma control subjects were examined at
onemonthafter injuryandoneyearafter injury.Oneyear
post-trauma, the mTBI group (those taking less than one
hour to show ability to follow commands) did not differ
significantlyonastatisticalbasisfromthetraumacontrol
group in their ability to perform a comprehensive neu-
ropsychological test battery. Larrabee (2012) has stated
in his recent work that using samples of convenience
that do not control for the effects of non-head traumatic
injury can cause quite different research outcomes. He
critically noted that many studies in the research litera-
ture of mTBI are poorly controlled due to the absence of
appropriate trauma controls. The importance of adding
a psychologist to the assessment team of a neuropsychi-
atric condition in order to perform PVT and SVT and
improvediagnosticprecision, specificity, andsensitivity
of diagnoses, has been outlined previously by Granacher
(2003, 2008, 2015).
3. Conceptualizing malingering and response
bias
As noted earlier, response bias and malingering have
been conceptualized as occurring typically across three
broad domains: psychopathology, cognitive impair-
ment, and physical or medical illness (Rogers, 2008;
Rogers & Granacher, 2011). The differential manifes-
tation of malingering across these three domains has
required the development of a variety of techniques for
detecting when it occurs. The present article is generally
focused on the detection of feigned psychopathology
and emotional/behavioral problems. Carone’s article
in this special issue is more focused on feigned
neurocognitive impairment. Nevertheless, we discuss
at times when psychopathological malingering mea-
sures capture elements of neurocognitive feigning (e.g.,
MMPI-2-RF Response Bias Scale).
Psychopathological symptoms represent internal
states experienced by the individual, which are most
often revealed through the person’s behavior and self-
report. Rogers (2008) and Rogers and Bender (2013)
have detailed the methods developed to detect the dis-
simulation of psychopathology. Detection strategies
are generally focused around two examinee themes -
an unsophisticated understanding of psychopathology
and an inconsistency between reported symptoms and
observed behavior. Most psychopathology malingering
detection strategies are based on the notion that indi-
viduals feigning symptoms do not have a sophisticated
understanding of the intricacies of psychopathology.
One common strategy, the Rare Symptoms approach,
considers the frequency of psychopathology symp-
toms (Rogers & Bender, 2013). Many dissimulators
report symptoms that are infrequently experienced
among patients with genuine illness. Those possess-
ing an unsophisticated understanding of the genuine
characteristics of mental illness might mistakenly over-
endorse symptoms that actually occur rarely among
bona fide patients.
Another method for detecting dissimulation involves
the Symptom Combination approach, in which dis-
simulators report combinations of symptoms that are
either unlikely or inconsistent with common mood and
psychotic disorders. This approach is utilized by two
structured interview approaches, the Miller Forensic
Assessment of Symptoms Test (M-FAST; Miller, 2001)
and the Structured Interview of Reported Symptoms-
2nd Edition (SIRS-2; Rogers, Sewell, & Gillard, 2010).
For example, the test item may first ask the evaluee
to affirm a particular symptom of a psychiatric con-
dition, one that may in fact be a legitimate symptom
(e.g., paranoia). If affirmed, the examiner then might
ask if that particular symptom occurred within the con-
text of another symptom (e.g., dizziness or headaches)
or a particular timeframe (e.g., only on Thursdays).
The feigning evaluee assumes that if the clinician is
asking these questions, which have face validity for psy-
chopathology, then a positive responsemust indicate the
presence of greater symptom severity.
Another method of detecting dissimulation, the
Reported versus Observed approach, involves compar-
ing the evaluee’s report of symptoms with behavioral
observations. In the most extreme sense of this concept,
insurance companies hire private investigators to follow
litigants with the hopes of “catching” them engaged
in activities inconsistent with their claimed disability
(e.g., low back pain litigant repairing a roof). For clin-
icians, dissimulation can be suspected if an evaluee’s
report of symptoms is inconsistent with the clinician’s
observations of the patient.
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In summary, the malingering of psychopathology
often represents a naı¨ve understanding of the gen-
uine characteristics of disorders, which leads to over-
reporting of symptoms. A particular challenge in neu-
ropsychiatricevaluationsis that litigatedconditionssuch
as TBIs often manifest themselves in psychological,
somatic, and cognitive sequelae. Symptoms associated
with neuropsychiatric injuries can include cognitive
problems, such as loss of attention/concentration, mem-
oryloss,mentalconfusion,andspeechimpairmentalong
with various somatic complaints, such as headaches,
nausea, and pain in the head, neck, and back regions.
Often, patients do not discriminate these symptoms as
either cognitive or somatic, and rather report them as
‘bodily’ experiences. Nicholson and Martelli (2004)
noted that patients often describe somatic and neurolog-
ical complaints as a “unitary experience” (p. 3). These
complaints may either be reported in conjunction with
psychological problems, such as Posttraumatic Stress
Disorder (PTSD) if the injuries were sustained in a trau-
maticevent suchasanaccidentorassault.Consequently,
the use of employing multiple measures that utilize vari-
ous detection strategies is often recommended (Rogers,
2008; Rogers & Granacher, 2011).
One conceptual link between the three domains
of malingering (psychopathology, cognitive, somatic/
medical) involves the notion of symptom expectancy.
Expectations play a significant role in an individual’s
appraisal and experience of health (Hahn, 1999) and can
shape health for better or worse. Exploring the role of
expectancy in the area of neurological injuries, some
have suggested it plays a significant role in symptom
presentation. Gunstad and Suhr (2002) explored symp-
tom expectancies for various conditions following an
automobile accident. The authors presented participants
with a vignette describing a car accident and one of
four distinct post-accident consequences: head injury,
back injury, posttraumatic stress, or depression. Par-
ticipants were then asked to complete a questionnaire
that described various cognitive, somatic, and emotional
symptom/complaints as if they had just experienced the
accident. Participants simulating head injury, posttrau-
matic stress, and depression expected equivalent rates
of overall symptoms, memory/cognitive complaints,
somatic concerns, and distracter symptoms, though
head-injured individuals reported fewer affective symp-
toms than those portraying psychological disorders.
Overall, Gunstad and Suhr’s results suggest that most
individuals display a relative lack of specificity in symp-
tom expectation for various disorders. Framing these
results within the context of malingering, it would be
expected that individuals feigning problems follow-
ing a neurological injury would malinger symptoms
from all three domains of functioning. Consequently,
instruments developed to detect over-reporting or mis-
representation of symptoms across all three domains
(e.g., MMPI-2-RF) are recommended.
Particularly challenging in neuropsychiatric evalua-
tions is the detection of feigned medical and physical
dysfunction. In forensic neuropsychiatric settings, indi-
viduals may intentionally misrepresent physical com-
plaints. Unlike the domains of cognitive impairment and
psychopathology, the detection of somatic malingering
has received much less attention, despite the frequency
with which it occurs (Lanyon, 2003). The detection
of somatic malingering is difficult in light of several
other differential diagnoses in the Diagnostic and Sta-
tistical Manual of Mental Disorders (DSM-5; American
Psychiatric Association [APA], 2013), such as Somatic
Symptom Disorder, Conversion Disorder, and Facti-
tious Disorder, which present similarly during clinical
evaluations. The issues of incentive and intentionality
are important in differentiating between somatic malin-
gering and somatic symptom disorders (Slick, Sherman,
& Iverson, 1999). Malingering involves the conscious
distortion or exaggeration of symptoms for an external
incentive. The incentives of Somatic Symptom Disor-
der, Conversion Disorder, and Factitious Disorder are
psychological, or internal in nature. The descriptions
of these disorders note the incompatibility between
reported symptoms and recognized neurological and
medical conditions (APA, 2013).
As is the case with cognitive impairment, the detec-
tion of malingered somatic complaints is hampered
by the lack of a “gold standard” for this task. In its
absence, clinicians rely heavily on patients’ self-report
and measures developed by physicians, such as non-
organic signs of physical pain (e.g., Waddell’s signs
[Waddell, McCulloch, & Kummel, 1980]) and mea-
sures of physical effort on tests of isometric strength
and flexibility (Bianchini et al., 2005). Elevations on
self-report scales such as the Modified Somatic Per-
ception Questionnaire (MSPQ; Main, 1983) and Pain
Disability Index (PDI; Pollard, 1984) were recently
found to differentiate exaggerated somatic complaints
from bona fide pain patients (Crighton, Wygant, Apple-
gate, Umlauf, & Granacher, 2014). Additionally, the
MMPI-2-RF Infrequent Somatic Complaints (Fs) scale
has shown some utility in detecting somatic malinger-
ing (Sellbom, Wygant, & Bagby, 2012).
Research has found that self-reported somatic com-
plaints often occur in the presence of malingered
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cognitive impairment. Studies examining the symp-
tomatic complaints of individuals who demonstrate
poorperformanceonneuropsychological testing (which
is usually measured with SVTs), has found signifi-
cant and replicated patterns of self-reported somatic
complaints (as measured by the MMPI-2), including
pain, paresthesia, and malaise (Berry et al., 1995;
Larrabee, 1998; Wygant et al., 2007). Berry et al. (1995)
reported that compensating brain-injured patients had
their highest MMPI-2 Clinical scale scores on scales
capturing physical malfunctioning, concern with health,
and neurological complaints, including problems with
attention/concentration and mental confusion. Similar
results were reported by Larrabee (2003) in relation
to the MMPI-2 and Portland Digit Recognition Test
(PDRT; Binder & Willis, 1991). More recent research
has found that the relation between feigned cognitive
impairment and over-reported somatic and emotional
complaints exists in non-head injury cases as well.
Gervais, Wygant, Sellbom, and Ben-Porath (2011)
examined substantive scales of the MMPI-2-RF (Ben-
Porath & Tellegen, 2008) and performance on several
cognitivemalingeringmeasures inasampleofover1000
non-head injury disability claimants (predominantly
comprised of patients with chronic pain and anxiety-
related disorders). These authors found the highest
effect sizes comparing those who failed no cognitive
SVTs with those who failed multiple SVTs on RC1
(Somatic Complaints), RCd (Demoralization), and RC2
(Low Positive Emotions). Moreover, those who failed
cognitive SVTs also over-reported on the COG (Cog-
nitive Complaints) scale, which was similarly reported
by Gervais, Ben-Porath, and Wygant (2009). Sumanti,
Boone, Savodnik, and Gorsuch (2006) found similar
results with the Personality Assessment Inventory (PAI;
Morey, 2007). Examining a sample of non-head injury
disability litigants, these authors found litigants display-
ing non-credible cognitive performance had elevations
on the PAI Somatic Concerns, Depression, Anxiety,
Anxiety-Related Disorders, and Schizophrenia scales.
Similar results on the PAI were found by Whiteside and
colleagues (2010) in relation to poor performance on
the Test of Memory Malingering (TOMM; Tombaugh,
1996).
4. Malingering criteria
The DSM-5 (APA, 2013) defines malingering as
the intentional production of false or grossly exagger-
ated physical or psychological symptoms, motivated by
external, secondary gain, which mirrors the DSM-IV-
TR with regard to diagnostic language. The DSM-5
specifies that clinicians should consider the presence of
malingering in cases where the individual is involved
in legal proceedings. It should also be considered when
there is a discrepancy between the objective findings
of an assessment and self-report, when the individ-
ual’s presentation demonstrates a lack of cooperation
with the evaluation, or when the evaluee displays symp-
toms of antisocial personality disorder. Unfortunately,
despite calls for conceptual revisions to the DSM-5 in
terms of aligning the diagnostic definition of malin-
gering with emerging research in the field (Berry &
Nelson, 2010), our official psychiatric manual still
affords little assistance in terms of guiding the assess-
ment of malingering and response bias. Consequently,
clinicians and researchers have developed their own
sets of criteria to guide the structured assessment of
malingering, particularly in the areas of neurocogni-
tive and pain malingering (Bianchini, Greve, & Glynn,
2005; Slick et al., 1999). The assessment of malingered
emotional/psychological functioning and psychiatric
symptoms is guided by various stand-alone measures
(e.g., Structured Inventory of Reported Symptoms-2
[SIRS-2; Rogers, Sewell, & Gillard, 2010]) and embed-
ded “validity” scales in multiscale inventories such
as the Minnesota Multiphasic Personality Inventory-2
Restructured Form (MMPI-2-RF; Ben-Porath, 2008).
Slick et al. (1999) developed criteria to aid in the
assessment and diagnosis of malingered neurocog-
nitive dysfunction (MND). MND is conceptualized
dimensionally into possible, probable, and definite
malingering depending on the extent of supporting
evidence as determined by four different criteria. Cri-
teria A requires the presence of a substantial external
incentive, criteria B includes evidence from neuropsy-
chological testing, criteria C includes evidence from
self-report measures, and criteria D states that the
criteria B and C must not be fully accounted for by psy-
chiatric, neurological, or developmental factors. These
criteria incorporate various sources of data, including
inconsistent responses on traditional neuropsychologi-
cal measures, formal cognitive symptom validity tests,
and embedded validity scales on self-report measures
such as the MMPI-2-RF. The sensitivity and specificity
of a neuropsychiatric examination can be improved con-
siderably by also incorporating the Slick et al. (1999)
criteria to ensure that the assessment and diagnoses have
adequately addressed the possibility of malingered neu-
rocognitive dysfunction (MND). Since physicians often
note substantial discrepancies between outside medical
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records, history obtained from the injured person, and
their own findings and suspicions, psychological test
findings incorporating the schema of Slick criteria can
vastly improve the physician’s diagnostic capability.
Utilizing the conceptual model established by Slick
and colleagues (1999), Bianchini, Greve, and Glynn
(2005) developed another set of criteria to aid in
diagnosing malingered pain-related disability (MPRD).
The MPRD criteria added a set of criteria that incor-
porated evidence from physical evaluation that were
consistent with symptom feigning. Aside from this
addition, the remaining structure and decision rules for
the MPRD criteria are consistent with MND. Both of
these criteria address previous limitations of conceptu-
alizing malingering as a categorical phenomenon, and
move it towards a dimensional construct. Utilizing neu-
ropsychological testing, clinical interviews, self-report
measures, and physical examinations, these criteria
account for exaggeration of neurocognitive, psychi-
atric/psychological, and somatic symptoms.
5. Response bias measures
In addition to cognitive malingering measures (which
are reviewed by Carone in this special issue), foren-
sic psychologists and psychiatrists primarily rely on
self-report measures to assess feigned neuropsychiatric
conditions. Three such measures used quite often in
forensic evaluations are the Personality Assessment
Inventory (PAI; Morey, 2007), Minnesota Multipha-
sic Personality Inventory-2 (MMPI-2; Butcher et al.,
2001), and MMPI-2-Restructured Form (MMPI-2-RF;
Ben-Porath & Tellegen, 2008/2011).
The PAI remains a particularly popular instrument
in forensic evaluations (Archer et al., 2006). Neverthe-
less, two particular challenges exist in using the PAI in
neuropsychiatric settings for the detection of malinger-
ing.First,while themeasurehaswell-validated response
bias indicators (Sellbom & Bagby, 2008), they are posi-
tioned to capture exaggerated psychiatric symptoms
(particularly severe psychopathology), but have limited
research examining their ability to capture the types of
symptoms often exaggerated in neuropsychiatric evalu-
ations. Morey, Warner, and Hopwood (2007) noted that
elevations (particularly high elevations) on the Somatic
Complaints (SOM) scale (and subscales) can be used in
combination with the PAI validity scales and external
information to identify individuals malingering somatic
problems.
Second, the number of studies examining the PAI
in medico-legal (e.g., psychological injury, civil foren-
sic litigation, neuropsychiatric) settings is much less
than the MMPI (Young, 2014). Two studies have found
that individuals evidencing non-credible neurocogni-
tive symptoms produced elevated scores on somatic and
internalizing scales on the PAI (Sumanti et al., 2006;
Whiteside et al., 2010). Hopwood, Orlando, and Clark
(2010) examined the PAI validity scales’ ability to dis-
criminate between chronic pain patients and college
students feigning chronic pain. While the PAI valid-
ity scales exhibited strong effect sizes discriminating
the pain patients from college simulators, the authors
cautioned against using the scales in clinical practice
due to low sensitivity. Classification accuracy of these
scales was improved by use of a discriminant function
incorporating numerous PAI validity and clinical scales.
The MMPI-2 (Butcher et al., 2001) has a long his-
tory of use in medical settings. Given its vast research
base and ability to measure broad aspects of per-
sonality and psychopathology, the MMPI-2 has also
been used extensively in medico-legal settings. The
MMPI-2 Restructured Form (MMPI-2-RF) was devel-
oped by Ben-Porath and Tellegen in 2008 as a revised
version of the MMPI-2, in line with contemporary
conceptualizations of personality and psychopathol-
ogy. The substantive scales of the MMPI-2-RF provide
useful clinical impressions in neurorehabilitation set-
tings, with regard to chronic pain treatment (e.g.,
Aguerrevere, Greve, & Bianchini, 2013), spinal-cord
stimulator implants (Block, Ben-Porath, & Marek,
2013), assessment of epilepsy (e.g., Locke et al., 2010),
neuropsychiatric disease (Granieri et al., 2013), and
neurocognitive functioning (e.g., Stroescu, Salinas,
Nahab, & Stringer, 2011), among others.
While the MMPI-2 remains very popular among
clinicians, the MMPI-2-RF may actually show more
utility in forensic neuropsychiatric evaluations. First
of all, it is considerably shorter than the MMPI-2
(338 vs. 567 items). Second, and perhaps most rel-
evant to the current article, the MMPI-2-RF validity
scales offer distinct measures of symptom exaggera-
tion of three domains of functioning discussed earlier.
In addition to capturing response consistency and
under-reporting, the 5 over-reporting scales can capture
emotional over-reporting (F-r: Infrequent Responses),
exaggerated severe psychopathology (e.g., psychosis)
(Fp-r: Infrequent Psychopathology Responses), non-
credible somatic complaints (Fs: Infrequent Somatic
Responses), non-credible neurocognitive and somatic
complaints (FBS-r: Symptom Validity), and symptoms
associated with poor effort on performance validity tests
(RBS: Response Bias Scale; Gervais et al., 2007).
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Previous research has examined the MMPI-2-RF
over-reporting validity scales in a variety of contexts,
including exaggeration of emotional symptoms and
feigned severe psychiatric disorders (Rogers, Gillard,
Berry, & Granacher, 2011; Sellbom & Bagby, 2010),
and in disability settings (Gervais et al., 2011; Sellbom
et al., 2013; Tarescavage et al., 2013; Wygant et al.,
2009, 2010, 2011; Youngjohn, Wershba, Stevenson,
Sturgeon, & Thomas, 2011).
Wygant, Ben-Porath, Arbisi, Berry, Freeman, and
Heilbronner (2009) showed that FBS-r and Fs dif-
ferentiate between participants reporting non-credible
somatic symptoms and bona fide, non-litigating med-
ical patients. They also found that the F-r scale was
useful in detecting exaggerated emotional complaints
in this setting. In 2010, Wygant et al. found that
RBS was associated with cognitive (SVT performance
among disability claimants. Sellbom, Wygant, and
Bagby (2013) examined the validity scales with indi-
viduals asked to intentionally malinger physical health
problems and compared their responses to a group of
somatoform patients and genuine medical patients. Fs
was sensitive to somatic malingering, whereas the Fp-r
scale was the most specific. Fs and Fp-r were both
able to differentiate the somatic malingering group
from the somatoform and medical illness groups. While
FBS-r had the highest overall sensitivity differentiating
non-credible somatic complaints from genuine medi-
cal illness, it could not distinguish somatic malingering
from somatoform disorder.
The MMPI-2-RF validity scales have also been
examined in neuropsychological settings. Youngjohn
et al. (2011) utilized the MMPI-2-RF to examine trau-
matic brain injury (TBI) litigants who had either passed
or failed effort tests. They found that although the FBS-
r, Fs, and F-r scales were not significant predictors of
TBI severity, FBS-r showed a significant relationship to
symptom validity test performance. Exaggerated mem-
ory complaints have been examined in relationship to
the MMPI-2-RF validity scales, and the RBS has exhib-
ited success in identifying this form of response bias
(Gervais et al., 2008, 2010). Using an archival sam-
ple of non-head injury disability-related referrals, RBS
added incrementally to other over-reporting measures
in assessing self-reported memory complaints (Gervais
et al., 2010).
The MMPI-2 and MMPI-2-RF have been examined
in relation to the criteria for Malingered Neurocogni-
tive Dysfunction (MND) and Malingered Pain-Related
Disability (MPRD) (Bianchini et al., 2008; Greve et al.,
2006; Schroeder et al., 2012; Wygant et al., 2011).
Greve and colleagues (2006) found that FBS exhibited
good classification (sensitivity and specificity) in iden-
tifying MND among 259 traumatic brain injury (TBI)
patients and 133 general clinical neuropsychological
patients. Utilizing a sample of simulated malinger-
ers and chronic pain patients, Bianchini et al. (2008)
found that the MMPI-2 validity scales accurately dif-
ferentiated malingerers from non-malingerers based
on the MPRD criteria. More recently, Wygant and
colleagues (2011) examined the MMPI-2-RF over-
reporting validity scales in individuals undergoing
compensation-seeking evaluations for disability in rela-
tion to the MND and MPRD criteria. They found that
Fs and FBS-r were good measures of non-credible neu-
rocognitive and somatic symptoms. Schroeder et al.
(2012) examined the MMPI-2-RF over-reporting scales
in relation to the MND criteria among TBI patients and
found that the scales exhibited excellent specificity and
good sensitivity in differentiating litigating TBI patients
classified as probable malingers from non-malingerers.
6. Case examples
We have selected two cases to illustrate some of the
points raised in this article. Both of these cases were
referred for forensic neuropsychiatric evaluation sec-
ondary to civil litigation. Both involved litigants who
display evidence of symptom exaggeration and possible
feigning. However, as Silver (2015, this issue) indi-
cates, not all invalid symptom reporting is indicative
of malingering.
6.1. Case 1
The first case involved a 36-year-old male being
examined at the request of his employer to determine
if he retained neuropsychiatric impairment as a result
of an alleged workplace injury. He was working his
customary occupation as a tree trimmer on the date
of his injury. A large limb fell onto his head while
he was wearing a hardhat and rendered him uncon-
scious. He was transported to a level 1 trauma center by
helicopter. His field Glasgow Coma Scale (GCS) score
was 13 with E = 3, V = 4, and M = 6. Upon arrival to
the trauma center, his GCS score was 15. The neuro-
logical examination was non-focal, but he perseverated
and kept asking, “Where am I?” He was diagnosed in
the emergency department with concussion and was
admitted to hospital for a brief stay. CT of the head
revealed a small left parietal scalp hematoma with no
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evidence of skull fracture or other evidence of injury
to brain parenchyma. He required no stitches to the
head.
Upon examination by the second author (RPG) two
years post injury, the examinee presented an extraordi-
nary number of mental and neuropsychiatric symptoms
known generally to be inconsistent with a concussion.
For instance, he complained of depression, sadness,
nervousness, poor concentration, loss of memory, con-
fusion, irritability, difficulty with thinking, flashbacks
to the accident, excessive counting of objects, fear of
germs, and fear of touching doorknobs. He admitted
his flashbacks were not specific to the accident, but
were flashbacks of other accidents he had “imagined.”
Neurologically, he complained of headaches, numb-
ness and tingling with weakness and poor balance.
In his sleep review, he claimed only to sleep four
hours nightly, but he required no naps whatsoever. He
also reported choking during sleep and that others had
observed him to stop breathing, but he denied daytime
somnolence.
Regarding his past medical history, the examinee was
not born prematurely and had no evidence of birth injury
or neurodevelopmental delay. He was able to function in
school and reported no history of attention deficit disor-
der or learning impairment. He had never been injured
in a prior motor vehicle accident, and had never been in
a coma, had a skull fracture, or undergone any surgery.
He was taking an extraordinary amount of medication
at the time of this examination, which included queti-
apine 700 mg nightly. His prior psychiatric history was
negative. His family history included no familial evi-
dence of psychiatric, neuropsychiatric, or neurological
illness. In his social history, he admitted to dropping
out of school after the 10th grade to go to work and he
never obtained a GED. He had been married twice and
divorced once, and he had three biological children. He
had been jailed once previously but claimed an inabil-
ity to know the charge that caused his incarceration. He
never entered military service. His wife was disabled,
and he also reported that he did not plan to return to
work at any time in the future.
Table 1
Case study data
Case 1 Case 2
Gender/Age/Education Male/36/10 Female/24/12
Neuroimaging Results Initial CT revealed a scalp hematoma but, no evidence
of parenchymal injury. Follow-up CTs were normal.
Initial CT revealed global edema with
effacement of sulci. Second CT on day 1
of injury revealed ventriculostomy with
subarachnoid hemorrhage. Third CT at 13
days post-injury revealed bifrontal
hygromas.
Additional medical findings Initial GCS in the field revealed confusion with E = 3,
V = 4, M = 6, T = 13. At emergency department,
GCS = 15 with non-focal neurologic examination.
She was pregnant at impact and lost the
fetus. GCS varied from 3T to 5T during
transit. She remained comatose. Follow-up
MRI 6 years post-injury revealed multiple
areas of chronic encephalomalacia.
MMPI-2-RF scale T score T score
VRIN-r 58 48
TRIN-r 58 50
F-r 120 120
Fp-r 85 85
Fs 99 115
FBS-r 89 99
RBS 120 118
L-r 57 52
K-r 28 31
TOMM Trial 2% 64% 90%
TOMM Retention % 50% N/A
LMT % 40% 98%
VSVT Easy % 79% 96%
VSVT Difficult % 13% 58%
Note. CT = computed tomography. GCS = Glasgow Coma Scale. E = Eye. V = Verbal. M = Motor. T = Total. MMPI-2-RF=Minnesota Multiphasic
Personality Inventory-2 Restructured Form. VRIN-r = Variable Response Inconsistency-Revised. TRIN-r = True Response Inconsistency-Revised.
F-r = Infrequent Responses. Fp-r = Infrequent Psychopathology Response. Fs = Infrequent Somatic Responses. FBS-r = Symptom Validity.
RBS = Response Bias Scale. L-r = Uncommon Virtues. K-r = Adjustment Validity. TOMM = Test of Memory Malingering. LMT = Letter Memory
Test. VSVT = Victoria Symptom Validity Test.
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The examinee’s mental status examination revealed
him to be an energetic man who was not mentally or
physically slow or sluggish. He vociferously argued
his case that he was unable to work and that he had
been badly injured by his accident. Nevertheless, he
independently completed a complex 22-page medical
questionnaire. His handwriting was without evidence
of tremor or other neurological findings. He did not
appear to be depressed, in spite of his protestations, nor
was he anxious. His language was intact for expression
and reception, and he was fluent. He gave no history
of delusions or hallucinations. His neurological exam-
ination was non-focal. Nevertheless, as indicated in
Table 1, this individual exhibited very poor effort on
three well-established performance validity measures.
Despite this, he still produced average scores on intel-
lectual and executive functions testing. However, his
poor effort likely impacted the extremely low scores on
various memory measures. His scores on the MMPI-
2-RF were highly reflective of emotional, somatic,
and neurocognitive symptom exaggeration. Diagnos-
tic impressions included severe symptom magnification
and poor cognitive effort, as well as an uncomplicated
concussion. His claim of persisting significant problems
resulting from a brain injury was deemed inconsistent
with the medical facts and clinical observations. The
evaluator concluded that he exhibited 0% neuropsychi-
atric impairment.
6.2. Case 2
The second case involved a 24-year-old female who
was injured in an automobile accident. She was exam-
ined at the request of an attorney representing the
defendant who allegedly injured this woman in the car
accident. The examination took place six years after her
injury. At examination and history taking, she reported
complete amnesia for the facts of the accident. At the
time of her accident, she was operating an SUV. Her ini-
tial Glasgow Coma Scale score taken by the ambulance
service indicated a GCS of 15. However, a helicopter
was dispatched to the scene, and by the time she was
loaded into the aircraft, her mental state had deteriorated
dramatically. She required intubation, and her GCS was
3T. At arrival to the level 1 trauma center after triage at
a local hospital, her GCS was 5T. She was found to have
a severe closed-head injury and a pregnancy. She lost
the pregnancy due to complications from the trauma.
Thispatient experiencedsignificantgeneralizedbrain
edema, which required intracranial decompression by
ventriculostomy. She had a complicated hospital stay,
and on day 13 of her injury, she was noted by imaging
to have bilateral frontal hygromas. On the 27th hospital
day, she was transferred to a rehabilitation hospital. Her
admission physician judged her to be at Rancho Level
V at the time of her admission. She had a gastric feed-
ing tube in place, a tracheostomy in place, and she could
follow only simple commands and did so inconsistently.
She had a slight left facial droop present on neurological
examination, with no other focal neurological findings.
At the time of her examination with the second
author, the patient was being treated at a local mental
health system near her home. She was reporting post-
traumatic stress disorder and a mood disorder due to
her brain injury. Her medications at the time of exam-
ination included triamterene and hydrochlorothiazide,
diazepam, and loratadine. All dosages were appropri-
ate. She also was taking an unspecified antidepressant.
After leaving the rehabilitation hospital, the patient
had to relocate to her father’s home. She denied any
prior history of head or brain injury, and she had never
been in a coma previously. She had fractured her left
clavicle in the subject accident, but it required no sur-
gical reconstruction. She denied prior pregnancies. She
denied a prior psychiatric history.
The patient’s neurological examination was non-
focal. Her mental status examination revealed her to be
pleasant and cooperative. She independently completed
a complex 22-page medical questionnaire. She was
fully oriented and understood the nature of the exam-
ination. She had a mildly constricted affective range
without anger or irritability, even though she subjec-
tively reported that she was quite irritable and angry at
times. She showed no evidence of undue anxiety while
discussing the accident, and she had absolutely no mem-
ory for it. This called into question her posttraumatic
stress disorder diagnosis.
MRI of the brain was obtained and demonstrated
focal areas of encephalomalacia, including the middle
right parietal cortex, periventricular white matter in the
right centrum semiovale, and a small focus present in
the left anterior centrum semiovale. Mild diffuse atro-
phy of brain was present, which was inappropriate for
her age. There was no shift of brain contents, and no
extra-axial fluid collections were present. Laboratory
testing for apolipoprotein E, 4 was negative.
As depicted in Table 1, this patient exhibited good
performance on two out of three performance validity
measures. Nevertheless, her scores on the MMPI-2-RF
were suggestive of symptom exaggeration across all
three domains of functioning. She also exhibited evi-
dence of feigning on the SIRS. Given her overall good
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performance on cognitive PVTs, her neuropsycholog-
ical test scores were considered to be representative
of her neurocognitive functioning. Scores on various
measures of memory, intellectual, and executive func-
tioning indicated impaired performance. Consequently,
she was diagnosed with a cognitive disorder due to
traumatic brain injury, as well as mood disorder and
personality change secondary to traumatic brain injury.
Her neuropsychiatric impairment was rated at 30%.
7. Conclusions
Forensic neuropsychiatric assessment requires thor-
ough consideration of malingering and response bias.
These evaluations are complicated due to the multiple
domains in which symptoms and impairment present.
Consequently, steps must be taken to ensure adequate
coverage of response bias across all three domains
of function. Performance and symptom validity mea-
sures should be routinely included in these evaluations.
Collaboration between psychiatry and psychology can
provide the optimal multi-method approach needed
for thorough neuropsychiatric assessment in forensic
cases. It is important to note, as illustrated in case 2,
that symptom exaggeration does not always preclude
genuine impairment.
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